Blurred vision as the first symptom of pancreatic cancer Authors: Dorottya Pasztor, Eszter Zöld, Éva Szekanecz, Sarolta Molnár, Nikolaos E Bechrakis, Eva Suranyi Published: 2026 ABSTRACT SummaryThis study presents a case and literature review of blurred vision as the first symptom of pancreatic cancer.A woman in her 60s was referred to our clinic because of visual impairment in her right eye. Ophthalmoscopic examination revealed a slightly elevated lesion in the macula. Primary tumour screening found a malignant mass in the cauda of the pancreas.According to Shields et al, pancreatic cancer with uveal metastasis has one of the least favourable survival rates. Our patient survived 20 months after the appearance of ophthalmic symptoms and had a good quality of life for a relatively long time. After reviewing all published data on intraocular metastases of pancreatic cancer, it becomes evident that the detection of the intraocular manifestation precedes the detection of the primary in half of the cases.Apparently, in fast-growing carcinomas, the symptomatology of the metastatic manifestation can precede the detection of the primary tumour. Background Metastasis to the eye and specifically to the choroid can be the first manifestation of a distant tumour disease.15 The most common primary tumours are breast, lung and prostate cancers.36 The dominant symptom in primary ocular manifestations is blurred vision and/or visual field defects, which can be the first sign of malignancy in one-third of the cases. It would be important for both ophthalmologists and general medical practitioners to be aware of this possibility to avoid unnecessary delays in primary tumour detection, considering that detection of both primary and metastatic manifestations can be challenging, especially when the lesions are small and not characteristic in appearance. The most frequent tumour metastatic to the choroid is breast cancer (37%), followed by the lung (27%), gastrointestinal tract (4%), kidney (4%), prostate (2%) and skin (2%).3 5 Primary pancreatic carcinoma as the site of origin for intraocular metastasis is extremely rare and has been described only a few times.35 717 Pancreatic cancer is the 14th most common cancer, usually diagnosed at an advanced stage resulting in a very poor prognosis, with a 5-year survival rate of less than 10% and the seventh highest cause of cancer death worldwide.8 10 It is observed that the incidence is increasing, predicting that pancreatic cancer will become the second-leading cause of tumour-related mortality by 2030 in the USA. Case presentation A woman in her 60s was referred to our clinic because of visual impairment in her right eye. In the general medical history, there were type 2 diabetes treated with insulin (HbA1C 7.1%), hypothyroidism, anti-HCV positive chronic hepatitis, controlled paroxysmal supraventricular tachycardia, coronary stent due to stenosis and COVID-19 infection 11 months earlier (she received two vaccinations after that). She had an upper respiratory tract infection with fever and hearing loss several weeks before the onset of ophthalmic symptoms. A complete ophthalmologic evaluation was performed. Her best corrected visual acuity deteriorated from 20/20 1 month before presentation to 20/50 at presentation in the right eye and remained stable at 20/20 in the left eye. Ophthalmoscopic examination revealed a slightly elevated lesion in the macular area with a small (<2.0 mm wide) choroidal nevus at the lower edge (figure 1). The colour of the non-pigmented lesion was orange, similar to that of the adjacent normal fundus. Ophthalmic ultrasound showed a tumour thickness of 1.4 mm lesion with medium to low inner reflectivity, and the largest basal diameter was 5.6 mm (figure 2). Optical coherence tomography showed a choroidal lesion under the retinal pigment epithelium with a slightly undulated surface (lumpy bumpy appearance) and subretinal fluid accumulation (figure 3). According to the history and appearance of the lesion, it was not characteristic of metastasis, but there was a possibility; therefore, the patient was referred to the oncology department for primary tumour screening. Fundus view on presentation showing an amelanotic mass at the macular region with a small melanocytic choroidal nevus at its lower margin (white asterisk). Ultrasound image of the metastatic lesion showing medium reflectivity. Optical coherence tomography image of the metastatic lesion with lumpy bumpy surface appearance and a discrete subretinal fluid accumulation under the fovea. Investigations The orbital MRI was negative. Laboratory reports showed elevated CA 72–4 (2x), CA 19–9 (24x), CA 125 and HE24 tumour marker levels. Multiple pulmonary metastases and involved lymph nodes were seen on chest CT. Whole abdominal and pelvic CT revealed a malignant mass in the cauda of the pancreas surrounded by pathologic lymph nodes, suspected metastatic lesions in the left adrenal gland and sclerotic metastases on the right side of the symphysis (figure 4). Biopsies of the pancreas and liver were performed. Histopathology confirmed the final diagnosis of pancreatic ductal adenocarcinoma metastatic to the liver with multiple bone metastases and pleural dissemination (figure 5). The patient received six cycles of FOLFIRINOX, a combination of chemotherapy for advanced pancreatic cancer (folinic acid, 5-fluorouracil, irinotecan and oxaliplatin). CT scan of the abdomen showing pancreatic CA with involved lymph nodes. Histopathological image of the pancreatic adeno-CA. Outcome and follow-up On ophthalmic control 5 months after presentation, the appearance of the lesion changed, becoming yellow-brown and mottled (figure 6). The thickness was the same, and the basal diameter increased. Imaging modalities showed progression of the primary tumour and metastases; therefore, the therapy was changed to gemcitabine+nab-paclitaxel. After temporary remission, the tumour progressed again, and capecitabine was administered orally. Two months later on her last ophthalmic control, her best corrected visual acuity in the right eye increased from 20/50 to 20/20, and the lesion was almost flat (figure 7). The patient died as a consequence of systemic tumour progression 20 months after presentation. Fundus view after 3 months of treatment showing subtotal regression. Fundus view after 12 months of treatment showing total regression. The study was performed in accordance with the tenets of the Declaration of Helsinki, and informed consent was obtained from the patient. The Institutional Review Board approved the study. Discussion Awareness of the possibility of pancreatic adenocarcinoma manifesting primarily as choroidal metastasis is important for ophthalmologists, general practitioners and oncologists. Approx. in one-third of uveal metastases from a distant primary, the detection of ocular metastases has preceded the diagnosis of the primary tumour.3 5 6 The most common primary site is the lung, 37% of cases, the second is the breast, 7% of cases, and in 50% of cases, the primary tumour will never be found.3 5 Pancreatic carcinoma as the site of origin is extremely rare and has been described only a few times (table 1).35 7 9 1117 Table 1All published case reports and general summaries of pancreatic cancers metastatic to the uveaPrevious case reportsNumber of cases before primary cancer diagnosis (9)Number of cases after primary cancer diagnosis (11)Sex F/MAgeType of primary cancerOther metastases at presentationTreatmentFollow-upCommentsRing, 19671F60Carcinoma of the body of the pancreas (autopsy)Lymph node, bone etc.Cyclophosphamide photocoagulationDied after 12 monthsCase reportSolomon, 19741F72Islet cell carcinoma (autopsy)LungNoneDied after 12 monthsCase reportCastillo, 1995 (article in French)1M45Pancreatic cancerLymph nodeNoneDied after 5 monthsCase reportShields, 19971MGeneral summary of uveal metastasesLin, 20011M52Pancreatic tail cancerYesNoneDied after 6 monthsCase report1M63NAYesTeletherapyDiedCase reportNasser, 20021F72AdenocarcinomaYesTeletherapyDied after 2 monthsCase reportShah, 20111M54Adenocarcinoma (autopsy)Lung, brain, right supraclavicular LNTeletherapyDied after 7 monthsGeneral summary of uveal metastases4Adenocarcinoma, carcinoidYesBrachytherapyTwo of them diedGeneral summary of uveal metastasesShields, 20183Died after a mean of 4.2 monthsGeneral summary of uveal metastases5Died after a mean of 4.2 monthsGeneral summary of uveal metastasesSingh, 20221M28AdenocarcinomaLiver, spleenChemotherapyDiedCase report All published case reports and general summaries of pancreatic cancers metastatic to the uvea According to Shields et al, uveal metastases arise from the pancreas in only 1% of all cases.3 Since the literature review on pancreatic cancer metastatic to the choroid by Shah et al in 2011, another four case reports have been published.121417 18 The first article they found was written in 1974 which cited four more previous papers about intraocular metastases from primary pancreatic tumours. According to these references, the first case of pancreatic carcinoma metastatic to the eye was reported likely in 1914 by Arisawa in Klinische Monatsblätter für Augenheilkunde. The article was written in German and cannot be found on the internet. There was an article in 1962 written by Hart, which is not available on the internet either. The third cited article from 1967 by Albert et al mentions one case of metastasis from pancreatic origin, but it is not written whether to the eye, orbit or adnexa. The first actually relevant report of bilateral uveal and left optic nerve metastases from pancreatic cancer was written in 1967 by Ring.11 In this case, a 59-year-old woman developed several abdominal, lower extremity and facial symptoms; she was diagnosed and treated with metastatic cancer of unknown origin. Six months later, ocular symptoms started, and she died at the age of 61. Correct diagnosis was possible only after autopsy, which revealed pancreatic cancer. After reviewing all published data on intraocular metastases of pancreatic cancer, it becomes evident that the detection of the intraocular manifestation precedes the detection of the primary in half of the cases. A similar finding has been described in lung adenocarcinoma, where choroidal metastases can precede the detection of the primary tumour in the lung.19 In contrast, breast cancer metastases to the choroid occur and are usually detected after the manifestation of the primary tumour. 6Apparently, in fast-growing carcinomas, the symptomatology of the metastatic manifestation can precede the detection of the primary tumour. Therefore, it is even more important to raise awareness in the medical community that visual symptoms can be the primary finding in patients with metastasising fast-growing carcinoma. According to Shields et al, pancreatic cancer with uveal metastasis has one of the least favourable survival rates (0% at 5 years in their study); the patients died after a mean of 4.2 months.3 5 Our patient survived 20 months after the appearance of ophthalmic symptoms, and for a relatively long time, she had a good quality of life. On the one hand, the incidence of pancreatic cancer is increasing; on the other hand, oncological systemic treatments have undergone tremendous developments in the past few years.8 10 20 21 Although in the past, metastatic manifestations of the choroid were treated mainly by irradiation, nowadays, the mainstay lies in systemic treatment strategies, which have both an impact on prolonged patients’ survival, as well as better functional preservation and patients’ quality of life, just as in our case. Learning points In fast-growing carcinomas, the symptomatology of metastatic manifestations may precede the detection of the primary tumour. In fast-growing carcinomas, the symptomatology of metastatic manifestations may precede the detection of the primary tumour. Pancreatic cancer with uveal metastasis has one of the least favourable survival rates. Pancreatic cancer with uveal metastasis has one of the least favourable survival rates. Intraocular manifestation precedes the detection of the primary in half of the cases. Intraocular manifestation precedes the detection of the primary in half of the cases. It is important to raise awareness in the medical community that visual symptoms can be the primary finding. It is important to raise awareness in the medical community that visual symptoms can be the primary finding.